Current:Home > FinanceFDA advisers support approval of RSV vaccine to protect infants-LoTradeCoin
FDA advisers support approval of RSV vaccine to protect infants
View Date:2024-12-23 18:16:57
Advisers to the Food and Drug Administration recommended that the agency should approve the first vaccine to protect infants from RSV, or respiratory syncytial virus. But some of the experts expressed reservations about the adequacy of data in support of the vaccine's safety.
In a two-part vote, the experts voted unanimously, 14-0, that the available data support the effectiveness of the Pfizer vaccine in preventing severe RSV-related respiratory illness. They then voted 10-4 that the data supports the vaccine's safety.
RSV is a leading cause of infant hospitalization in the U.S. From 58,000 to 80,000 children younger than 5 years old are hospitalized each year with RSV infections, according to the Centers for Disease Control and Prevention. Infants 6 months old and younger are at elevated risk for severe RSV illness.
The votes came after a day of testimony and discussion during a public meeting of the agency's expert panel on vaccines. The FDA isn't bound to follow the advice of its expert panels, but it usually does. A decision on the vaccine for infants is expected by late August.
The vaccine isn't given to babies. Instead, pregnant people are immunized during the late second to third trimester of pregnancy. The antibodies they develop against RSV pass to the fetus in the womb and later protect the newborn.
A clinical study involving 7,400 people found the vaccine had 81.8% efficacy in preventing severe respiratory illness caused by RSV within three months after birth and 69.4% in the first six months.
There was some evidence that those who got vaccinated might have been more likely to give birth prematurely. And committee members worried about pregnant people getting the vaccine at the same time as some other vaccines, such as TDAP (tetanus-diphtheria-pertussis), because it could interfere with their effectiveness.
"I worry that if preterm births are in any way a consequence of this vaccine, that would be tragic," said Dr. Paul Offit, professor of pediatrics at The Children's Hospital of Philadelphia. He voted no on the adequacy of safety data.
The same Pfizer vaccine is under FDA review to protect people 60 and older people from RSV. Advisers voted to support approval of the vaccine at February meeting.
Separately, in a first, the agency approved an RSV vaccine from drugmaker GSK in early May for people 60 and older.
veryGood! (2)
Related
- What do nails have to say about your health? Experts answer your FAQs.
- Break in the weather helps contain a wildfire near South Dakota’s second-biggest city
- Civil rights activist Sybil Morial, wife of New Orleans’ first Black mayor, dead at 91
- Travis Barker's FaceTime Video Voicemails to Daughter Alabama Barker Will Poosh You to Tears
- Taylor Swift gifts 7-year-old '22' hat after promising to meet her when she was a baby
- Grand Canyon pipeline repairs completed; overnight lodging set to resume
- Kentucky high school student, 15, dead after she was hit by school bus, coroner says
- Pregnant Gypsy Rose Blanchard Shares Glimpse at Her Baby in 20-Week Ultrasound
- Man accused of killing American tourist in Budapest, putting her body in suitcase: Police
- Man sentenced to over 1 year in prison for thousands of harassing calls to congressional offices
Ranking
- DWTS' Gleb Savchenko Shares Why He Ended Brooks Nader Romance Through Text Message
- A US Navy sailor is detained in Venezuela, Pentagon says
- Why Passengers Set to Embark on 3-Year Cruise Haven't Set Sail for 3 Months
- Variety of hunting supplies to be eligible during Louisiana’s Second Amendment sales tax holiday
- 32 things we learned in NFL Week 10: Who will challenge for NFC throne?
- Guns flood the nation's capital. Maryland, D.C. attorneys general point at top sellers.
- Florida doctor found liable for botching baby's circumcision tied to 6 patient deaths
- UGA fatal crash survivor settles lawsuit with athletic association
Recommendation
-
Ex-Marine misused a combat technique in fatal chokehold of NYC subway rider, trainer testifies
-
Workers at General Motors joint venture battery plant in Tennessee unionize and will get pay raise
-
Elton John Shares Severe Eye Infection Left Him With Limited Vision
-
Many think pink Himalayan salt is the 'healthiest' salt. Are the benefits real?
-
Dick Van Dyke says he 'fortunately' won't be around for Trump's second presidency
-
Ezra Frech wins more gold; US 400m runners finish 1-2 again
-
Man arrested at Trump rally in Pennsylvania wanted to hang a protest banner, police say
-
Israelis protest as Netanyahu pushes back over Gaza hostage deal pressure | The Excerpt